Experience

The Center for Advancing Innovation Inc.

• United States
• Business Consulting and Services
• 1 - 100 Employee

• Consultant Intern

  • Nov 2016 - Present

  1. Launched the Freedom from Cancer Startup Challenge collaborated with the Laura and John Arnold Foundation and MedImmun. 2. Participated in the implementation of a novel commercialization accelerator across 12+ institutions and the creation of an ecosystem from 100+ universities, 125 industry advisors, and 20 research foundations. 3. Evaluate 300+ cancer inventions, offered through CAI startup challenges by various research institutes (e.g. NIH), to identify those with the highest commercial viability. Evaluations would include the following steps: Market analysis; Customer segmentation analysis; Technology viability; Funding analysis; Operational feasibility analysis. 4. Performed 150+ stakeholder analysis and engagement to organizations and industry leaders that may have interest in participating. 5. Made strategic recommendations after performing extensive research on assigned topics: various information sources to include prospect interactions with our website analytics, customer pipeline strategies, and other established research that defines market sizing. 6. Evaluated letters of intent, elevator speeches, business plans, live pitches, and financial models Trained teams on specific items such as valuation, R&D planning, FDA paths, etc. Show less



The National Institutes of Health

• United States
• Biotechnology Research
• 700 & Above Employee

• Postdoctoral Fellow

  • Aug 2015 - Present

  1. Analyzed and reviewed the development status and prospects of therapeutics and diagnostics for CNS diseased. 2. Worked on the pre-clinical development of novel analgesics, heroin antibody, and therapeutics for drug abuse, based on new mechanisms such as biased GPCR activation and interactions between opioid receptors. 3. Attended international research conferences twice, gave presentations, and won awards. 4. Reviewed 10+ SCI papers. 1. Analyzed and reviewed the development status and prospects of therapeutics and diagnostics for CNS diseased. 2. Worked on the pre-clinical development of novel analgesics, heroin antibody, and therapeutics for drug abuse, based on new mechanisms such as biased GPCR activation and interactions between opioid receptors. 3. Attended international research conferences twice, gave presentations, and won awards. 4. Reviewed 10+ SCI papers.